Marinobufagenin in hypertensive patients with obstructive sleep apnea

Cellular and Molecular Biology

Volumn 52, Issue 8, 2006, Pages 24-27

  Zvartau, N E ^a   Conrady, A O ^a   Sviryaev, Y V ^a   Rotari, O P ^a   Merkulova, N K ^a   Kalinkin, A L ^b   Shlyakhto, E V ^a   Bagrov, A Y ^c,d  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^b Center for Sleep Disorders   (Russian Federation)

^c SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Hypertension; Marinobufagenin; Na K ATPase; Obstructive sleep apnea

Indexed keywords

CARDIOTONIC STEROID; MARINOBUFAGENIN; STEROID HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SLEEP APNEA SYNDROME;

ADULT; BLOOD PRESSURE DETERMINATION; BUFANOLIDES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OUABAIN; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

LAKE VICTORIA MARBURGVIRUS; STROPHANTHUS GRATUS;

EID: 34249051940     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T756     Document Type: Article

References (28)

1. Anderson, D.E. Cardiorenal effects of behavioral inhibition of breathing. Biol. Psychol. 1998, 49: 151-163.
2. Anderson, D.E., Bagrov, A.Y., and Austin, J.L. Inhibited breathing decreases renal sodium excretion. Psychosom. Med. 1995, 57: 373-380.
3. Bagrov, A.Y., Dmitrieva, R.I., Fedorova, O.V., Kazakov, G.P., Roukoyatkina, N.I., and Shpen, V.M. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity. Am. J. Hypertens. 1996, 9: 982-990.
4. Bagrov, A.Y., and Fedorova, O.V. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension. Front. Biosci. 2005, 10: 2250-2256.
5. Bagrov, A.Y., Fedorova, O.V., Austin-Lane, J.L., Dmitrieva, R.I., and Anderson, D.E. Endogenous marinobufagenin-like immunoreactive factor and Na,K-ATPase inhibition during voluntary hypoventilation. Hypertension. 1995; 26, 781-788.
6. Bagrov, Y.Y., Manusova, N.B., Egorova, I.A., Fedorova, O.V., and Bagrov, A.Y. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Front. Biosci. 2005, 10: 2257-2262.
7. Bagrov, Y.Y., Manusova, N.B., Egorova, I.A., Frolova, E.V., Fedorova, O.V., and Bagrov, A.Y. Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus. Dokl. Biol. Sci. 2005, 404: 333-337.
8. 2+ stores and cell responsiveness. Am. J. Physiol. 1993, 264: C1367-C1387.
9. Buckalew, V.M. Endogenous digitalis-like factors. An historical overview. Front Biosci. 2005, 10: 2325-2334.
10. Fedorova, O.V., Dorofeeva, N.A., Lopatin, D.A., Lakatta, E.G., and Bagrov, A.Y. Phorbol diacetate potentiates Na-K-ATPase inhibition by a putative endogenous ligand, marinobufagenin. Hypertension. 2002, 39: 298-302.
11. Fedorova, O.V., French, A.W., and Anderson, D.E. Inhibition of erythrocyte Na,K-ATPase activity during anticipatory hypoventilation in micropigs. Am J Hypertens. 1996, 9: 1126-1131.
12. Fedorova, O.V., Talan, M.I., Agalakova, N.I., Droy-Lefaix, M.T., Lakatta, E.G., and Bagrov, A.Y. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension. Hypertension. 2003, 41: 505-511.
13. Fedorova, O.V., Talan, M.I., Agalakova, N.I., Lakatta, E.G., and Bagrov, A.Y. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation. 2002, 105: 1122-1127.
14. Ferrari, P., Ferrandi, M., Valentini, G., and Bianchi, G. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+K+ ATPase alterations in ouabain and adducin-dependent hypertension. Am. J. Physiol. 2006, 290: R529-R535.
15. Fletcher, E.C. Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and sympathetic activity. Sleep, 2000, 23(Suppl 4): S127-S131.
16. Fuse, K., Satoh, M., Yokota, T., Ohdaira, T., Muramatsu, Y., Suzuki, E., and Arakawa, M. Regulation of ventilation before and after sleep in patients with obstructive sleep apnoea. Respirology. 1999, 4: 125-130.
17. Levinson, P.D., McGarvey, S.T., Carlisle, C.C., Eveloff, S.E., Herbert, P.N., and Millman, R.P. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 1993, 103: 1336-1342.
18. Narkiewicz, K., and Somers, V.K. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J. Hypertens. 1997, 12: 1613-1619.
19. Nieto, F.J., Young, T.B., Lind, B.K., Shahar, E., Samet, J.M., Redline, S., D'Agostino, R.B., Newman, A.B., Lebowitz, M.D., and Pickering, T.G. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000, 283: 1829-1836.
20. Ng, Y.C., Tolerico, P.H., and Book C.B. Alterations in levels of Na(+)-K(+)-ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats. Am. J. Physiol. 1993, 265, E243-E251.
21. Paci, A., Marrone, O., Lenzi, S., Prontera, C., Nicolini, G., Ciabatti, G., Ghione, S., and Bonsignore, G. Endogenous digitalislike factors in obstructive sleep apnea. Hypertens. Res. 2000, 23(Suppl): S87-S91.
22. Peppard, P.E., Young, T., Palta, M., and Skatrud, J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 2000, 342: 1378-1384.
23. Punjabi, N.M., and Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol. 2005, 99: 1998-2007.
24. Quednau, B., Rosskopf, D., Reusch, H.P., Luft, F.C., and Siffert, W. Enhanced Na(+)-H+ exchanger activity and NHE-1 mRNA levels in human lymphocytes during metabolic acidosis. Am. J. Physiol. 1994, 266: C480-C488.
25. Rios, E.J., Fallon, M., Wang, J., and Shimoda, L.A. Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cells. Am. J. Physiol. 2005, 289: L867-L874.
26. Somers, V.K., Dyken, M.E., Clary, M.P., and Abboud, F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. 1995, 96: 1897-1904.
27. Sweeny, G., and Klip, A. Regulation of the Na/K ATPase by insulin: why and how? Mol. Cell. Biochem. 1998, 182: 121-133.
28. Tepel, M., Sanner, B.M., van der Giet, M., and Zidek, W. Increased sodium-proton antiporter activity in patients with obstructive sleep apnoea. J. Sleep. Res. 2000, 9: 285-291.